Aurobindo gets FDA OK for generic Robaxin
Patients with painful musculoskeletal conditions will soon have a new generic treatment.
The Food and Drug Administration has given Aurobindo the green light for methocarbamol tablets in a dosage strength of 750 mg.
Aurobindo’s product is the generic of Auxilium’s Robaxin-750 tablets.
Methocarbamol tablets are indicated for an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.